Avantor, Inc. $AVTR Shares Purchased by Squarepoint Ops LLC

Squarepoint Ops LLC grew its stake in shares of Avantor, Inc. (NYSE:AVTR) by 418.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,006,446 shares of the company’s stock after buying an additional 812,203 shares during the quarter. Squarepoint Ops LLC’s holdings in Avantor were worth $9,964,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently made changes to their positions in the company. Private Management Group Inc. raised its holdings in Avantor by 50.4% during the fourth quarter. Private Management Group Inc. now owns 2,456,859 shares of the company’s stock worth $28,156,000 after purchasing an additional 823,572 shares in the last quarter. GSA Capital Partners LLP bought a new position in Avantor during the 2nd quarter valued at $800,000. Oppenheimer Asset Management Inc. bought a new position in Avantor during the 2nd quarter valued at $805,000. Assenagon Asset Management S.A. increased its position in shares of Avantor by 425.0% during the 2nd quarter. Assenagon Asset Management S.A. now owns 556,871 shares of the company’s stock valued at $5,513,000 after purchasing an additional 450,801 shares during the period. Finally, Brickwood Asset Management LLP increased its position in shares of Avantor by 6,891.9% during the 4th quarter. Brickwood Asset Management LLP now owns 3,184,043 shares of the company’s stock valued at $36,489,000 after purchasing an additional 3,138,504 shares during the period. 95.08% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on AVTR. Morgan Stanley boosted their price objective on Avantor from $10.00 to $14.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 30th. Wolfe Research raised Avantor from a “strong sell” rating to a “hold” rating in a report on Thursday, July 30th. Sanford C. Bernstein initiated coverage on shares of Avantor in a research report on Friday, June 26th. They issued a “market perform” rating and a $10.50 price target on the stock. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $13.00 price target on shares of Avantor in a report on Thursday, July 30th. Finally, Jefferies Financial Group upgraded shares of Avantor from an “underperform” rating to a “hold” rating and set a $13.00 price objective for the company in a research report on Wednesday, July 29th. Two investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $12.47.

Avantor Price Performance

Shares of NYSE:AVTR opened at $14.88 on Friday. Avantor, Inc. has a one year low of $7.26 and a one year high of $15.93. The stock has a fifty day moving average of $13.01 and a 200-day moving average of $10.10. The company has a market capitalization of $10.06 billion, a PE ratio of -17.71, a price-to-earnings-growth ratio of 11.23 and a beta of 0.89. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.18 and a current ratio of 1.78.

Avantor (NYSE:AVTR) last issued its earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.19 by $0.02. The business had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.61 billion. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The company’s quarterly revenue was up .5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.24 EPS. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. As a group, equities analysts anticipate that Avantor, Inc. will post 0.81 EPS for the current fiscal year.

Avantor Company Profile

Avantor, Inc (NYSE: AVTR) is a global provider of products and services used in the life sciences, healthcare and advanced technology industries. The company supports research, drug discovery, biopharmaceutical production, clinical and diagnostic activities, and other laboratory-based applications.

Its offerings include laboratory chemicals and reagents, consumables, equipment, instruments, production materials and related services. Avantor also provides supply-chain, procurement and other technical solutions designed to help customers manage laboratory and manufacturing operations.

Avantor serves customers across pharmaceutical and biopharmaceutical companies, healthcare providers, academic and government institutions, medical laboratories and industrial businesses.